# Azitra Inc (AZTR)

Source: https://www.quantisnow.com/company/AZTR
Generated: 2026-11-21T12:04:36.401Z

- Ticker: AZTR
- Exchange: AMEX
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2023
- SEC CIK: 0001701478

## Latest AZTR news and filings

- 2026-11-16 22:15 UTC [SEC Schedule 13D] [SEC Form SCHEDULE 13D filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-schedule-13d-filed-by-azitra-inc-6794851)
- 2026-11-12 21:30 UTC [Earnings] [Azitra, Inc. Announces Q3 2026 Results and Provides Business Updates](https://www.quantisnow.com/insight/azitra-inc-announces-q3-2026-results-and-provides-business-updates-6788363)
- 2026-11-12 21:15 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-results-of-operations-and-6788095)
- 2026-11-12 21:13 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-azitra-inc-6788026)
- 2026-11-12 15:29 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by Azitra Inc](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-azitra-inc-6787070)
- 2026-11-10 13:40 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-other-events-financial-statements-6783184)
- 2026-11-10 13:30 UTC [Azitra, Inc. to Present Research at BIO-Europe® Showing ATR-COSF Reduced Fine Lines and Improved Elasticity in Ex Vivo Human Skin Models](https://www.quantisnow.com/insight/azitra-inc-to-present-research-at-bio-europe-showing-atr-cosf-reduced-6783155)
- 2026-10-29 12:35 UTC [SEC Form 8-K] [SEC Form 8-K filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-azitra-inc-6762830)
- 2026-10-29 12:30 UTC [Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors](https://www.quantisnow.com/insight/azitra-inc-expands-eligibility-for-atr-04-phase-12-clinical-trial-6762803)
- 2026-10-26 12:50 UTC [SEC Form 8-K] [SEC Form 8-K filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-azitra-inc-6757206)
- 2026-10-26 12:45 UTC [Azitra, Inc. Announces Revitalizing Results from Ex Vivo Study of ATR-COSF Demonstrating Ability to Reduce Fine Lines and Improve Elasticity in Human Skin](https://www.quantisnow.com/insight/azitra-inc-announces-revitalizing-results-from-ex-vivo-study-of-6757195)
- 2026-10-22 20:15 UTC [SEC Form 8-K] [SEC Form 8-K filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-azitra-inc-6755240)
- 2026-10-16 12:00 UTC [Azitra, Inc. Announces Reverse Stock Split](https://www.quantisnow.com/insight/azitra-inc-announces-reverse-stock-split-6748699)
- 2026-10-01 12:10 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-other-events-financial-statements-6731536)
- 2026-10-01 12:00 UTC [Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance](https://www.quantisnow.com/insight/azitra-inc-advances-atr-04-phase-12-clinical-trial-to-cohort-6731514)
- 2026-09-28 20:50 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-entry-into-a-material-6727954)
- 2026-09-28 20:45 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-azitra-inc-6727941)
- 2026-09-08 12:05 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6707611)
- 2026-09-08 12:00 UTC [Conference Announcement] [Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference](https://www.quantisnow.com/insight/azitra-inc-to-present-at-the-hc-wainwright-28th-annual-6707582)
- 2026-08-21 12:05 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-other-events-financial-statements-6690783)
- 2026-08-21 12:00 UTC [Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards](https://www.quantisnow.com/insight/azitra-inc-regains-compliance-with-nyse-american-continued-listing-standards-6690775)
- 2026-08-14 20:36 UTC [SEC Form SCHEDULE 13G filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-azitra-inc-6683357)
- 2026-08-14 20:31 UTC [SEC Form SCHEDULE 13G filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-azitra-inc-6683255)
- 2026-08-12 21:00 UTC [Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates](https://www.quantisnow.com/insight/azitra-inc-announces-q2-2026-results-and-provides-business-updates-6678453)
- 2026-08-12 20:55 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-results-of-operations-and-6678405)
- 2026-08-12 20:54 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-azitra-inc-6678402)
- 2026-07-15 20:10 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-other-events-financial-statements-6638296)
- 2026-07-15 14:11 UTC [/C O R R E C T I O N -- Azitra, Inc./](https://www.quantisnow.com/insight/c-o-r-r-e-c-t-i-o-n-6638025)
- 2026-07-15 14:10 UTC [Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity](https://www.quantisnow.com/insight/azitra-inc-announces-breakthough-repeat-dose-and-anti-wrinkle-ex-vivo-6637963)
- 2026-06-22 21:00 UTC [SEC Form SCHEDULE 13G filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-azitra-inc-6611128)
- 2026-06-18 20:30 UTC [SEC Form 4] [President and CEO Salva Francisco D. converted options into 4,064,050 shares, increasing direct ownership by 18,273% to 4,086,291 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-salva-francisco-d-converted-options-into-4064050-6608994)
- 2026-06-17 12:05 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-other-events-financial-statements-6605925)
- 2026-06-17 12:00 UTC [Conference Announcement] [Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond](https://www.quantisnow.com/insight/azitra-inc-ceo-issues-letter-to-shareholders-detailing-strategic-reorientation-6605907)
- 2026-06-16 21:28 UTC [Conference Announcement] [Azitra, Inc. to Present at 2026 BIO International Convention](https://www.quantisnow.com/insight/azitra-inc-to-present-at-2026-bio-international-convention-6605359)
- 2026-06-16 12:00 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-amendments-to-articles-of-6603952)
- 2026-06-04 20:15 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-azitra-inc-6589474)
- 2026-06-04 20:10 UTC [SEC Form 8-K] [Azitra Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/azitra-inc-filed-sec-form-8-k-other-events-financial-statements-6589381)
- 2026-06-04 20:05 UTC [Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting](https://www.quantisnow.com/insight/azitra-announces-adjournment-of-2026-annual-meeting-and-information-for-6589238)
- 2026-06-03 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-effect-filed-by-azitra-inc-6585626)
- 2026-05-27 20:32 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Azitra Inc](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-azitra-inc-6575135)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AZTR
- Earnings history: https://www.quantisnow.com/earnings/AZTR
- Dividend history: https://www.quantisnow.com/dividends/AZTR
- Insider transactions: https://www.quantisnow.com/insiders/AZTR
- Options chain: https://www.quantisnow.com/options/AZTR
- SEC 8-K filings only: https://www.quantisnow.com/company/AZTR/8-k
- RSS and alerts for AZTR: https://www.quantisnow.com/docs/rss-feeds.md
